Home > Healthcare > Medical Devices > Therapeutic Devices > Interventional Cardiology & Peripheral Vascular Devices Market

Interventional Cardiology & Peripheral Vascular Devices Market Share

Report ID: GMI1964
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Interventional Cardiology & Peripheral Vascular Devices Market Share

The strategic landscape of the interventional cardiology & peripheral vascular devices market consists of companies such as:

B. Braun Melsungen AG
C.R. Bard (BD)
Cardinal Health
Medtronic plc
Teleflex Inc., W. L.
Gore & Associates Inc.
Cook Medical,
Boston Scientific Corporation
Biotronik SE & Co. K
AngioDynamics
and Abbott Laboratories

These firms are focusing on advanced product developments and other strategies to gain a competitive edge and reinforce their foothold in the industry.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for interventional cardiology & peripheral vascular devices exceeded USD 22 billion in 2022 and will register over 7.5% CAGR through 2023-2032, considering low physical activity engagement and growing chronic disease incidence.

Ambulatory surgical centers segment is poised to depict over 8% CAGR through 2023-2032, driven by the shifting preference toward minimally invasive procedures.

North American interventional cardiology & peripheral vascular devices market is slated to surpass USD 13 billion by 2032, owing to the presence of state-of-the-art healthcare facilities for minimally invasive procedures for cardiac conditions.

Major manufacturers of interventional cardiology & peripheral vascular systems include B. Braun Melsungen AG, C.R. Bard (Becton Dickinson and Company), Cardinal Health, Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories, among others.